Biotrove Inc. Developed the OpenArray® platform, a high throughput gene expression and genotyping analysis system based on a flexible array format that enables researchers to perform more than 3,000 PCR genotyping or qPCR gene expression assays at a time.
Catalyst was a lead investor.
News / Links
LIFE Technologies (NASD: LIFE) in 2009